Neoen


Q1 24: Earnings in line with expectations, objectives confirmed

02/05/24 -"As expected revenues declined by 8% year-on-year and by 6% at constant Fx rates due to the entry into force of certain PPAs that allowed a reduction in the market exposure from 18% to 14%, and the ..."

Pages
72
Language
English
Published on
02/05/24
You may also be interested by these reports :
22/05/24
A challenging 2024E after a strong 2023. Downgrade to Add

20/05/24
We now account for the Q1 24 earnings. We have revised upwards the contribution of Flex Gen from renewables, which still seems a bit low to us based ...

17/05/24
Once again, we were surprised by the exceptional performance of GEMS, which achieved an EBIT of €1,458m compared to €1,606m in Q1 23. While Engie ...

16/05/24
Snam reported a solid Q1 supported by the growth in regulated revenues, which was partly offset by the lower contribution from the energy transition ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO